Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study to Detect Advanced Liver Disease Via AI-enabled Electrocardiogram

NCT: NCT05782283 · COMPLETED

NCT IDNCT05782283
StatusCOMPLETED
Start Date2023-04-18
Completion2025-09-01
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The overall objectives of this study are to determine the effectiveness of ACE 2.0 model in early detection of advanced liver fibrosis, and to determine the acceptance and barriers for use of an AI-enabled algorithm for prediction of liver disease in primary care.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑